Investment Rating - The report initiates coverage with a "Buy" rating for the company [4][9]. Core Viewpoints - Ruike Laser is a leading manufacturer of fiber lasers in China, focusing on the research, production, and sales of high-power fiber lasers and their core components. The company's products are widely used across various industries, including laser marking, cutting, welding, and medical applications [1][14]. - The company emphasizes R&D investment, with a 2024 R&D expenditure of 35.48 million yuan, representing a year-on-year increase of 4.97%, accounting for 11.10% of its revenue [2][29]. - The traditional market for mid-to-low power applications is becoming saturated, leading to price competition and a decline in revenue and profit for 2024. However, the report highlights growth potential in high-power and ultrafast laser markets, particularly in sectors like new energy vehicles and aerospace [3][32]. - The report forecasts revenue for 2025-2027 to be 3.532 billion, 4.040 billion, and 4.559 billion yuan, respectively, with net profits of 233 million, 306 million, and 380 million yuan, indicating a recovery trend [4][35]. Summary by Sections Company Overview - Ruike Laser specializes in high-power fiber lasers and offers a diverse product matrix, including continuous, pulsed, and ultrafast lasers, serving various industries such as automotive, aerospace, and medical [1][14][18]. R&D and Technological Advancements - The company has launched 13 new products in 2024, including a 200kW ultra-high power fiber laser, which has achieved several global firsts [2][29]. The focus on high-end manufacturing and precision processing is evident in its R&D strategy [29][31]. Market Dynamics - The report notes that while the traditional low-to-mid power market faces challenges, there is significant room for growth in high-power applications, particularly in defense and emerging technologies like anti-drone systems [3][33][32]. Financial Projections - The financial outlook includes projected revenues and net profits for 2025-2027, with corresponding EPS and PE ratios indicating a positive growth trajectory [4][35]. The company is expected to recover from the current downturn in 2024, with a forecasted revenue increase of 10.48% in 2025 [5][35].